Predictors of disease severity in children hospitalized for pertussis during an epidemic

Pediatric Infectious Disease Journal

Volumn 34, Issue 4, 2015, Pages 339-345

  Marshall, Helen ^a,b   Clarke, Michelle ^b   Rasiah, Kavita ^b   Richmond, Peter ^c,d   Buttery, Jim ^e   Reynolds, Graham ^f   Andrews, Ross ^g   Nissen, Michael ^h   Wood, Nick ⁱ   Mcintyre, Peter ⁱ  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f The Australian National University   (Australia)

^g MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^h ROYAL CHILDREN'S HOSPITAL   (Australia)

ⁱ CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

children; hospitalization; pertussis; pertussis scoring system

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; PERTUSSIS VACCINE;

ADOLESCENT; AGE; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY ASSESSMENT; EPIDEMIC; FEVER; HOSPITALIZED CHILD; HUMAN; INDEPENDENT VARIABLE; INFANT; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MIXED INFECTION; NEWBORN; OBSERVATIONAL STUDY; PEDIATRIC HOSPITAL; PERTUSSIS; PERTUSSIS SEVERITY SCORE; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; TERTIARY CARE CENTER; VACCINATION; AUSTRALIA; CLINICAL TRIAL; FEMALE; HOSPITAL; HOSPITALIZATION; MALE; MULTICENTER STUDY; PATHOLOGY; PRESCHOOL CHILD; PROGNOSIS; SEVERITY OF ILLNESS INDEX; WHOOPING COUGH;

ADOLESCENT; AUSTRALIA; CHILD; CHILD, PRESCHOOL; EPIDEMICS; FEMALE; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TERTIARY CARE CENTERS; WHOOPING COUGH;

EID: 84937642483     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000577     Document Type: Article

References (32)

1. Australian Government Department of Health. National Notifiable Diseases Surveillance System [12 July 2012]. Available from: http://www9.health. gov.au/cda/source/rpt-3.cfm.
2. Australian Institute of Health and Welfare. Principal diagnosis data cubes. Australian Government; 2012 [18 March 2012]. Available from: http:// www.aihw.gov.au/hospitals-data/principal-diagnosis-data-cubes/.
3. Naidu L, Chiu C, Habig A, et al. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010. Commun Dis Intell Q Rep. 2013;37(suppl):S1-S95.
4. Spokes PJ, Quinn HE, McAnulty JM. Review of the 2008-2009 pertussis epidemic in NSW: notifications and hospitalisations. N S W Public Health Bull. 2010;21:167-173.
5. Wood N, Quinn HE, McIntyre P, et al. Pertussis in infants: preventing deaths and hospitalisations in the very young. J Paediatr Child Health. 2008;44:161-165.
6. Preziosi MP, Halloran ME. Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity. Clin Infect Dis. 2003;37:772-779.
7. Australian Government Department of Health. Pertussis case definition. Commonwealth of Australia; [03 September 2013]. Available from: http:// www.health.gov.au/internet/main/publishing.nsf/Content/cda-surveilnndss-casedefs-cd-pertus.htm.
8. El Saleeby CM, Bush AJ, Harrison LM, et al. Respiratory syncytial virus load, viral dynamics, and disease severity in previously healthy naturally infected children. J Infect Dis. 2011;204:996-1002.
9. Fodha I, Vabret A, Ghedira L, et al. Respiratory syncytial virus infections in hospitalized infants: Association between viral load, virus subgroup, and disease severity. J Med Virol. 2007;79:1951-1958.
10. Surridge J, Segedin ER, Grant CC. Pertussis requiring intensive care. Arch Dis Child. 2007;92:970-975.
11. Elliott E, McIntyre P, Ridley G, et al. National study of infants hospitalized with pertussis in the acellular vaccine era. Pediatr Infect Dis J. 2004;23:246-252.
12. Halperin SA, Wang EE, Law B, et al. Epidemiological features of pertussis in hospitalized patients in Canada, 1991-1997: report of the Immunization Monitoring Program-Active (IMPACT). Clin Infect Dis. 1999;28:1238-1243.
13. Nuolivirta K, Koponen P, He Q, et al. Bordetella pertussis infection is common in nonvaccinated infants admitted for bronchiolitis. Pediatr Infect Dis J. 2010;29:1013-1015.
14. Crowcroft NS, Andrews N, Rooney C, et al. Deaths from pertussis are underestimated in England. Arch Dis Child. 2002;86:336-338.
15. Langkamp DL, Davis JP. Increased risk of reported pertussis and hospitalization associated with pertussis in low birth weight children. J Pediatr. 1996;128(5, pt 1):654-659.
16. Baxter D. Impaired functioning of immune defenses to infection in premature and term infants and their implications for vaccination. Hum Vaccin. 2010;6:494-505.
17. van den Berg JP, Westerbeek EA, van der Klis FR, et al. Transplacental transport of IgG antibodies to preterm infants: A review of the literature. Early Hum Dev. 2011;87:67-72.
18. Slack MH, Schapira D, Thwaites RJ, et al. Acellular pertussis vaccine given by accelerated schedule: response of preterm infants. Arch Dis Child Fetal Neonatal Ed. 2004;89:F57-F60.
19. Vazquez L, Garcia F, Ruttimann R, et al. Immunogenicity and reactogenicity of DTPa-HBV-IPV/Hib vaccine as primary and booster vaccination in low-birth-weight premature infants. Acta Paediatr. 2008;97:1243-1249.
20. Mooi FR, van Loo IH, van Gent M, et al. Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis. 2009;15:1206-1213.
21. Octavia S, Sintchenko V, Gilbert GL, et al. Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008-2010. J Infect Dis. 2012;205:1220-1224.
22. Lam C, Octavia S, Ricafort L, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014;20:626-633.
23. Advisory Committee on Immunization Practices (ACIP). Summary Report. June 22-23, 2011.Department of Health and Human Services Centers For Disease Control and Prevention. Atlanta, Georgia. Available at: http://www. cdc.gov/vaccines/acip/meetings/downloads/min-Archive/min-jun11.pdf.
24. Halperin BA, Halperin SA. The reemergence of pertussis and infant deaths: is it time to immunize pregnant women? Future Microbiol. 2011;6:367-369.
25. Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr. 2008;152:655-60, 660.e1.
26. White OJ, Rowe J, Richmond P, et al. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine. 2010;28:2648-2652.
27. Wood N, McIntyre P, Marshall H, et al. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J. 2010;29:209-215.
28. National Health and Medical Research Council. The Australian Immunisation Handbook. 10th ed. Canberra, Australia:Commonwealth of Australia; 2013.
29. Barlow RS, Reynolds LE, Cieslak PR, et al. Vaccinated children and adolescents with pertussis infections experience reduced illness severity and duration, Oregon, 2010-2012. Clin Infect Dis. 2014;58:1523-1529.
30. Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10 year community study. Br Med J (Clin Res Ed). 1988;296:612-614.
31. Nilsson L, Lepp T, von Segebaden K, et al. Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance. Vaccine. 2012;30:3239-3247.
32. Quinn HE, Snelling TL, Macartney KK, et al. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics. 2014;133:e513-e519.